This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parra, A.
Right arrow Articles by Soriano, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parra, A.
Right arrow Articles by Soriano, F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2002, p. 859-862, Vol. 46, No. 3
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.3.859-862.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Optimal Dose of Amoxicillin in Treatment of Otitis Media Caused by a Penicillin-Resistant Pneumococcus Strain in the Gerbil Model

Araceli Parra,1 Carmen Ponte,1 Carlos Cenjor,2 Gloria García-Calvo,1 María José Giménez,3 Lorenzo Aguilar,3 and Francisco Soriano1*

Departments of Medical Microbiology,1 Otolaryngology, Fundación Jiménez Díaz,2 Medical Department, GlaxoSmithKline, Madrid, Spain3

Received 16 April 2001/ Returned for modification 20 September 2001/ Accepted 16 November 2001

Amoxicillin at doses of 0.2 to 5 mg/kg of body weight was administered for the treatment of pneumococcal otitis media in a gerbil model. Doses greater than or equal to 2.5 mg/kg, which resulted in concentrations in middle ear fluid of >=1.4 µg/ml and concentrations in serum higher than the MIC (1 µg/ml) for >=14% of the dosing interval, were both clinically and bacteriologically effective.

* Corresponding author. Mailing address: Department of Medical Microbiology, Fundación Jiménez Díaz, Avenida de Reyes Católicos 2, 28040 Madrid, Spain. Phone: 34-91-5.44.73.87. Fax: 34-91-549.47.64. E-mail: fsoriano{at}fjd.es.

Antimicrobial Agents and Chemotherapy, March 2002, p. 859-862, Vol. 46, No. 3
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.3.859-862.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chiavolini, D., Pozzi, G., Ricci, S. (2008). Animal Models of Streptococcus pneumoniae Disease. Clin. Microbiol. Rev. 21: 666-685 [Abstract] [Full Text]  
  • Garbutt, J., Rosenbloom, I., Wu, J., Storch, G. A. (2006). Empiric first-line antibiotic treatment of acute otitis in the era of the heptavalent pneumococcal conjugate vaccine.. Pediatrics 117: e1087-e1094 [Abstract] [Full Text]  
  • Garbutt, J., St. Geme, J. W. III, May, A., Storch, G. A., Shackelford, P. G. (2004). Developing Community-Specific Recommendations for First-Line Treatment of Acute Otitis Media: Is High-Dose Amoxicillin Necessary?. Pediatrics 114: 342-347 [Abstract] [Full Text]  
  • MacGowan, A. P., Noel, A. R., Rogers, C. A., Bowker, K. E. (2004). Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model. Antimicrob. Agents Chemother. 48: 2599-2603 [Abstract] [Full Text]  
  • Parra, A., Ponte, C., Cenjor, C., Martinez-Marin, C., Soriano, F. (2004). Effect of Antibiotic Treatment Delay on Therapeutic Outcome of Experimental Acute Otitis Media Caused by Streptococcus pneumoniae Strains with Different Susceptibilities to Amoxicillin. Antimicrob. Agents Chemother. 48: 860-866 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»